SOLNA, Sweden - Aerocrine AB (OMX Nordic Exchange: AERO) receives US FDA market clearance for the company’s next generation device, NIOX VERO®. Launch planned for Q1 2015. Aerocrine received notification that the United States Food and Drug Administration (FDA) has granted market clearance for NIOX VERO, the company’s next generation device for measuring Fractional exhaled Nitric Oxide (FeNO) levels in the clinical setting. “The portability and patient-centered improvements provided by NIOX VERO will make it more practical for specialists as well as primary care physicians to make FeNO testing a routine part of identifying and managing allergic airway inflammation in patients with diagnosed or suspected asthma,” said Scott Myers, CEO of Aerocrine, AB. NIOX VERO is a small, point-of-care device that provides a patient’s FeNO score in about 1 minute after a simple 10-second exhalation. The device improves on the previous generation NIOX MINO® by including a rechargeable battery for portability within the clinical setting and an integrated visual display to help patients complete a successful exhalation. Aerocrine’s NIOX MINO and now NIOX VERO are the only FeNO measurement devices cleared by the FDA and commercially available in the United States. “FeNO testing is an important addition to clinicians’ tool set because it is the only way to objectively identify and manage allergic airway inflammation, which is the leading cause of asthma symptoms,” said Dr. Kathleen Rickard, Chief Medical Officer at Aerocrine. “Routine FeNO testing helps clinicians find hidden and under-treated allergic airway inflammation, which has been shown to help reduce asthma exacerbations by up to 50 percent compared to usual care.” Asthma is one of the most common diseases in the United States, affecting 8-10% of the population and accounting for an estimated 90 million patient interactions with healthcare providers each year. Over half of those patient interactions are with adult and pediatric primary care practitioners. The disease has no cure and proper diagnosis and management of the disease are key to obtaining optimal control of a patient’s asthma. For more information about Aerocrine: Scott Myers, Chief Executive Officer, Aerocrine AB, Phone: +1 970 368 0336 Dr. Kathleen Rickard, Chief Medical Officer, Aerocrine AB: +1 919 749 6708 Marshall Woodworth, Chief Financial Officer, Aerocrine AB: +1 919 749 8748 or +46 709 695 219 Or visit www.aerocrine.com About Aerocrine Aerocrine AB is a medical products company focused on the improved management and care of patients with inflammatory airway diseases. As the pioneer and leader in technology to monitor and manage airway inflammation, Aerocrine markets NIOX MINO® and NIOX VERO®. Both products enable fast and reliable management of airway inflammation and may therefore play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. Aerocrine is based in Sweden with subsidiaries in the U.S., Germany, Switzerland and the U.K. Aerocrine shares were listed on the Stockholm Stock Exchange in 2007. Aerocrine may be required to disclose the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 5:00 p.m. on November 6, 2014.
AEROCRINE AB RECEIVES US FDA MARKET CLEARANCE FOR NIOX
Top 10 Most Recent News Articles
Italian Wine Faces U.S. Slump and New Market Openings
American demand has put a cork in the easy story, and Italian wine producers cannot pretend otherwise. In the first nine months of 2026, U.S. imports of Italian wine dropped 18.4% by value. That is painful because the United States remains Italy's largest destination market by value, not some side shelf that can be ignored until conditions improve. Still, the broader U.S....
Continue Reading
BNY's December Conference Slot Merits a Careful Listen
A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...
Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth
A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...
Continue Reading
Early Dog Guarding Signs Matter Before a Sudden Growl
A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...
Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital
Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....
Continue Reading
1095 Days Finds the Army's Long, Ordinary War Life
A cracked barracks window can explain more than a polished battlefield legend. Dean R. Cherry's 1095 Days: Three Years in the Green Machine, newly released by Palmetto Publishing, puts its weight on the parts of Army life that war stories often shove into the background: cold, waiting, paperwork, arbitrary rules, lousy living conditions, and the private mental math of...
Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays
A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...
Continue Reading
Bank of America AML Claims Put Controls Under Fire
A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...
Continue Reading
A Parish Memoir That Sends Its Proceeds Back Home
Some books arrive with a thunderclap; this one shows up carrying a folding chair, a prayer book, and a memory that refuses to leave. You Give Them Something to Eat, the new memoir from Fr. Michael J Rieder, is built from more than a hundred short chapters rather than one grand, polished life story. That choice fits the material. Parish life is rarely a clean parade of...
Continue Reading
America's Group Adds Swansea to Its UK Auction Map
A Welsh Lane Joins a Larger Road Port Talbot just became a small but telling dot on America's Group's international map. The company has acquired Swansea Motor Vehicle Auction Limited, a long-standing South Wales wholesale and remarketing operation, and plans to run it under the G3 brand. This is not the sort of deal that makes markets levitate. It is the sort that tells...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring High ROIC Tech Stocks: Key Insights and Analysis
Understanding ROIC in Tech Stocks Return on Invested Capital (ROIC) is a vital indicator when evaluating a company's financial performance and investment potential. It reflects how efficiently a firm uses the capital invested by shareholders to generate profits. High ROIC values signal that a company is not only effective in utilizing its resources but may also be poised...
Continue Reading
Join AVITA Medical's Upcoming Investor Webinar Event
AVITA Medical Plans Informative Investor Webinar AVITA Medical, Inc. (NASDAQ: RCEL), known for its innovative approaches to acute wound care, is gearing up to host an insightful investor webinar. The CEO, Jim Corbett, alongside CFO, David O'Toole, will lead this engaging session and discuss the latest financial results and strategic business developments. Details of the...
Continue Reading
Labour Government's Budget Aims to Restore Market Stability
Introduction to the New Labour Budget The newly formed Labour government has introduced its first budget, aiming to restore confidence in the UK markets. With a focus on substantial tax increases and strategic spending control, this budget seeks to avoid the destabilizing impact seen during Liz Truss's tenure. The measures announced are designed to bolster the economy...
Continue ReadingBeacon Energy to Host Annual General Meeting This December
Beacon Energy's Annual General Meeting Update Beacon Energy plc (AIM: BCE, NYSE: BCE) is an oil and gas company dedicated to developing its onshore assets in Germany. Recently, the company confirmed that it is set to hold its Annual General Meeting (AGM) on December 18, 2024. This significant event will be hosted at 55 Athol Street, Douglas, Isle of Man, providing a prime...
Continue Reading
Okeanis Eco Tankers: Key Insights Ahead of Earnings Call
Anticipating Okeanis Eco Tankers' Upcoming Earnings Okeanis Eco Tankers (NYSE:ECO) is preparing to release its latest quarterly earnings report soon. Investors and analysts are keenly focused on what this announcement will bring, particularly in terms of earnings expectations and guidance for upcoming quarters. Expected Earnings Report Industry analysts anticipate that...
Continue Reading